The predictive impact of hematological inflammatory markers in detecting prostate cancer in patients with PI‐RADS 3 lesions on multiparametric magnetic resonance imaging

Documenti analoghi

• The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
  di: Paulius Aliukonis
  Pubblicazione: (2017)
• Head‐to‐head comparison of GA‐68 PSMA PET/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancer
  di: Mustafa Dinckal, et al.
  Pubblicazione: (2024)
• PSA Density and Lesion Volume: Key Factors in Avoiding Unnecessary Biopsies for PI‐RADS 3 Lesions
  di: Ali Ayranci, et al.
  Pubblicazione: (2024)
• Individualized Precision Prostate Biopsy Strategy for Patients With PI‐RADS Score 2: A Retrospective Multicenter Study
  di: Zhiyao Xu, et al.
  Pubblicazione: (2025)
• Influence of 5‐Alpha Reductase Inhibitors on PI‐RADS Scores and Prostate Cancer Detection: A Systematic Review and Meta‐Analysis
  di: Lian Qiong, et al.
  Pubblicazione: (2025)